This post is from a low-reputation account and contains an unverified outbound link. Be cautious before clicking external links.
Managing the side effects of high-risk Myelodysplastic Syndrome (MDS) treatment, such as fatigue and nausea, can be challenging but is essential for maintaining a good quality of life during therapy. High-risk MDS, a type of blood cancer that impacts the production of healthy blood cells, often requires intensive treatment that can lead to debilitating side effects.